Exploring Health LLC provides unique screening platforms for identifying potential anti-metastasis compounds in your compound library. The identified compounds can then be further validated by our multiple in vitro cell models as well as in vivo metastatic animal models. Currently, our high-throughput screening platform consists of a high-throughput microplate dispenser, cell incubators, a microplate reader, and other related softwares and analytical systems, which meet all your professional screening needs.